Diabetes
Conditions
Interventions
product management:give Philicare-UFG and accept the online management of health managers and doctors
product control:use Philicare-UFG without online management
management control:was given placebo and was administered online by health managers and doctors
blank control group:The blank control group was given placebo and was not managed.
Sponsors
The fifth affiliated hospital of Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Male and female aged 18-60 years; 2. BMI 24 kg/m2 to 35 kg/m2; 3. In the last three months, HbA1c has been detected between 6.5% to 9.0% and patients with type 2 diabetes who have been diabetic for no more than 5 years; orOGTT test was diagnosed as prediabetic patients; 4. Ability to comply with the management of doctors and health management; 5. Volunteer to participate in this study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. During pregnancy or lactation woman; 2. Ecg results indicate that there may be undiagnosed heart disease, requiring further diagnosis (such as significant conduction abnormalities, arrhythmias, etc.); 3. Previously diagnosed heart disease (coronary heart disease, rheumatic heart disease, cardiomyopathy, cardiac insufficiency) and cerebrovascular disease (cerebral hemorrhage, cerebral infarction); 4. Chronic kidney disease (chronic glomeruli, nephritis, chronic renal insufficiency, systemic disease and kidney); 5. Diabetic nephropathy; 6. The acute onset of gouty arthritis; 7. Creatinine level is 1.5 times higher than the upper limit (local laboratory); 8. ALT and/or AST are three times higher than the upper limit, or there are other obvious anomalies; 9. Severe liver disease, such as cirrhosis (mild, moderate fatty liver can be selected); 10. SBP>160mmHg and/or DBP>100mmHg hypertension (drug treatment); 11. Thyroid disease in treatment (especially hyperthyroidism or hypothyroidism); 12. Cancer; 13. Severe gastric ulcer and recurrent gastroesophageal reflux; 14. Pancreatitis; 15. Frequent hypoglycemia; 16. Mental disease (e.g.Depression, Bipolar disorder, Bulimia); 17. The operation has not yet fully recovered; 18. Weight loss over the last three months has been more than 5%; 19. Severe lactose intolerance; 20. Other intervention trials are under way; 21. Unable to be communicated by the health manager via the Internet or telephone.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight lossbefore and after the management; | — |
Secondary
| Measure | Time frame |
|---|---|
| The decrease of glycosylated hemoglobin (HbA1c) in type 2 diabetes mellitus.;OGTT transfer of patients with pre-diabetes mellitus.;Mend matters of FPG, TC, TG, LDL-C, HDL-C, BP;Changes in Body fat rate and WC; | — |
Countries
China
Contacts
Public ContactJianping Weng
The Fifth Affiliated Hospital of Sun Yat-sen University
Outcome results
None listed